TY  - GEN
TI  - Combination therapies**: Could TRPA1 antagonists be combined with disease-modifying approaches (anti-Aβ, anti-αSyn) for synergistic benefit in AD/PD?
AU  - Questions, Backfill Open
PY  - 2026
UR  - https://scidex.ai/artifact/open_question-6ab813b5-6633-4fdb-98c1-ded548e7d910
PB  - SciDEX
ER  -